Company Earnings UpdateCVS Health (NYSE: CVS) 1Q19 Results: Strong Aetna Performance Boosts Revenues, Prompts Guidance Raise Coresight Research May 3, 2019 Executive Summary CVS Health reported 1Q19 revenues of $61.6 billion, ahead of the consensus estimate and up 34.8% year over year. Adjusted EPS was $1.62, up 9.5% year over year and above the consensus estimate. CVS closed its acquisition of Aetna in Novesmber 2018, so this is the first full quarter of combined operations. For FY19, CVS raised adjusted EPS guidance to $6.75-6.90 from $6.68-6.88. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Consumer Sentiment Stabilizes… for Now; Plus, Inflation Awareness Rises: US Consumer Survey InsightsHoliday 2025: The Last Mile—Tariff-Driven Early Buying To Ease Peak Season Shipping RushShoptalk Spring 2025 “Shark Reef” Startup Pitch: Preview—12 Innovators Leveling Up the Customer Experience and Streamlining OperationsInnovator Profile: Novel—Driving Conversion and Boosting Loyalty with Branded Wallet Passes
